BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 23799213)

  • 1. The role of ¹³C-methacetin breath test for the non-invasive evaluation of nonalcoholic fatty liver disease.
    Fierbinteanu-Braticevici C; Plesca DA; Tribus L; Panaitescu E; Braticevici B
    J Gastrointestin Liver Dis; 2013 Jun; 22(2):149-56. PubMed ID: 23799213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive estimation of liver fibrosis in non-alcoholic fatty liver disease using the 13 C-caffeine breath test.
    Park GJ; Wiseman E; George J; Katelaris PH; Seow F; Fung C; Ngu MC
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1411-6. PubMed ID: 21557768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous 13C-methacetin breath test differentiates biliary atresia from other causes of neonatal cholestasis.
    Shteyer E; Lalazar G; Hemed N; Pappo O; Granot E; Yerushalmi B; Gross E
    J Pediatr Gastroenterol Nutr; 2013 Jan; 56(1):60-5. PubMed ID: 22695040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 13C-Methacetin Breath Testing in Patients with Non-Alcoholic Fatty Liver Disease.
    Kempiński R; Neubauer K; Wieczorek S; Dudkowiak R; Jasińska M; Poniewierka E
    Adv Clin Exp Med; 2016; 25(1):77-81. PubMed ID: 26935501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver function breath tests for differentiation of steatohepatitis from simple fatty liver in patients with nonalcoholic Fatty liver disease.
    Tribonias G; Margariti E; Tiniakos D; Pectasides D; Papatheodoridis GV
    J Clin Gastroenterol; 2014 Jan; 48(1):59-65. PubMed ID: 24335903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease.
    Demir M; Lang S; Nierhoff D; Drebber U; Hardt A; Wedemeyer I; Schulte S; Quasdorff M; Goeser T; Töx U; Steffen HM
    J Clin Gastroenterol; 2013 Sep; 47(8):719-26. PubMed ID: 23442837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.
    McPherson S; Stewart SF; Henderson E; Burt AD; Day CP
    Gut; 2010 Sep; 59(9):1265-9. PubMed ID: 20801772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive factors for nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).
    Fierbinteanu-Braticevici C; Baicus C; Tribus L; Papacocea R
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):153-9. PubMed ID: 21725512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitis.
    Portincasa P; Grattagliano I; Lauterburg BH; Palmieri VO; Palasciano G; Stellaard F
    Clin Sci (Lond); 2006 Aug; 111(2):135-43. PubMed ID: 16603025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 13C methacetin breath test for non invasive staging of liver fibrosis in patients with chronic hepatitis C.
    Fierbinteanu-Braticevici C; Papacocea R; Tribus L; Cristian B
    Indian J Med Res; 2014 Jul; 140(1):123-9. PubMed ID: 25222787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 13C-caffeine breath test detects significant fibrosis in patients with nonalcoholic steatohepatitis.
    Schmilovitz-Weiss H; Niv Y; Pappo O; Halpern M; Sulkes J; Braun M; Barak N; Rotman Y; Cohen M; Waked A; Tur-Kaspa R; Ben-Ari Z
    J Clin Gastroenterol; 2008 Apr; 42(4):408-12. PubMed ID: 18277896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry.
    Goetze O; Selzner N; Fruehauf H; Fried M; Gerlach T; Mullhaupt B
    Aliment Pharmacol Ther; 2007 Jul; 26(2):305-11. PubMed ID: 17593076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis.
    Schneider A; Caspary WF; Saich R; Dietrich CF; Sarrazin C; Kuker W; Braden B
    J Clin Gastroenterol; 2007 Jan; 41(1):33-7. PubMed ID: 17198062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.
    Kaneda H; Hashimoto E; Yatsuji S; Tokushige K; Shiratori K
    J Gastroenterol Hepatol; 2006 Sep; 21(9):1459-65. PubMed ID: 16911693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
    Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich CF; Caspary WF; Sarrazin C
    Aliment Pharmacol Ther; 2005 Jan; 21(2):179-85. PubMed ID: 15679768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis].
    Pfaffenbach B; Götze O; Szymanski C; Hagemann D; Adamek RJ
    Dtsch Med Wochenschr; 1998 Dec; 123(49):1467-71. PubMed ID: 9861887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.
    Shirin H; Aeed H; Shalev T; Sorin V; Stavinski S; Shahmurov M; Ilan Y; Avni Y
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1762-8. PubMed ID: 19120861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C-methacetin breath test correlates with clinical indices of liver disease severity in patients with primary biliary cirrhosis.
    Kochel-Jankowska A; Hartleb M; Jonderko K; Kaminska M; Kasicka-Jonderko A
    J Physiol Pharmacol; 2013 Feb; 64(1):27-33. PubMed ID: 23568968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.